Press Releases
Date Title and Summary View
Apr 30, 2015 HOLLISTON, Mass., April 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed James Green as a Class I director of the Board of Directors to fill the new vacancy created by Dr. Robert Dishman's retirement fro...
Apr 30, 2015 HOLLISTON, Mass., April 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial highlights for the three months ended March 31, 2015. Jeffrey A. Duchemin, President and Chief Executive Officer of Harvard Bioscienc...
Apr 21, 2015 HOLLISTON, Mass., April 21, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2015 before market trading hours on Thursday, April 30, 2015. A conference call to discuss the company's first q...
Feb 26, 2015 Acquisitions, Operational Improvements and Organic Growth Drive ResultsConference Call To Be Held at 11:00 AM ET Today HOLLISTON, Mass., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial highlights for ...
Feb 18, 2015 HOLLISTON, Mass., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, has appointed Ryan Atienza to Vice President of Sales, a newly created position, at its Denville Scientific subsidiary, effective...
Feb 13, 2015 HOLLISTON, Mass., Feb. 13, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its fourth quarter and year-end 2014 before market trading hours on Thursday, February 26, 2015. A conf...
Jan 8, 2015 Expected to Add $4 Million to $5 Million in Revenue in 2015Acquisition of Biomedical Instrumentation and Software Company Substantially Expands Harvard Bioscience's Impact in Electrophysiology Market HOLLISTON, Mass., Jan. 8, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a bro...
Dec 16, 2014 HOLLISTON, Mass., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2...
Nov 13, 2014 HOLLISTON, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, announced it will exhibit its life science equipment and instruments at the Society for Neuroscience 2014 Annual Meeting at the W...
Nov 10, 2014 HOLLISTON, Mass., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has appointed Bertrand Loy to its Board of Directors, effective immediately. Mr. Loy is President and CEO of Entegris Inc., a provider of yield-enhancing...
FirstPrevious
3
... NextLast
= add release to Briefcase